1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

WT Hughes, D Armstrong, GP Bodey… - Clinical Infectious …, 1997 - academic.oup.com
This is the first in a series of practice guidelines commissioned by the Infectious Diseases
Society of America through its Practice Guidelines Committee. The purpose of these …

Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections

HM Lamb, D Ormrod, LJ Scott, DP Figgitt - Drugs, 2002 - Springer
Ceftriaxone is a parenteral third-generation cephalosporin with a long elimination half-life
which permits once-daily administration. It has good activity against Streptococcus …

Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients

AL Oliveira, M De Souza, VMH Carvalho-Dias… - Bone marrow …, 2007 - nature.com
The incidence of Gram-negative bacteremia has increased in hematopoietic stem cell
transplant (HSCT) recipients. We prospectively collected data from 13 Brazilian HSCT …

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis

KG Lucas, AE Brown, D Armstrong… - … Journal of the …, 1996 - Wiley Online Library
BACKGROUND The management of pediatric oncology patients with fever and neutropenia
assumes that all patients are at risk for bacteremia, and therefore generally involves …

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low‐risk pediatric oncology patients: Randomized …

AS Petrilli, LS Dantas, MC Campos… - … : The Official Journal …, 2000 - Wiley Online Library
Background Infections are one of the major complications in children undergoing
chemotherapy. Monotherapy with either ciprofloxacin or ceftriaxone is safe and efficient in …

[HTML][HTML] Diagnóstico y tratamiento de la neutropenia febril en niños con cáncer: Consenso de la Sociedad Latinoamericana de Infectología Pediátrica

H Paganini, M Álvarez, MJ Araña Rosaínz… - Revista chilena de …, 2011 - SciELO Chile
PAGANINI, Hugo et al. Diagnóstico y tratamiento de la neutropenia febril en niños con
cáncer: Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev. chil …

Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections

JA Balfour, HM Bryson, RN Brogden - Drugs, 1996 - Springer
Synopsis The prototype carbapenem antibacterial agent imipenem has a very broad
spectrum of antibacterial activity, encompassing most Gram-negative and Gram-positive …

Infections in children with cancer: a continued need for the comprehensive physical examination

JJ Auletta, MA O'Riordan… - Journal of pediatric …, 1999 - journals.lww.com
Few studies have addressed the influence of profound myelosuppressive therapy in
contemporary protocols on infectious morbidity in pediatric oncology patients. This study …

[HTML][HTML] Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience

N Özdemir, G Tüysüz, N Çelik, L Yantri… - Turkish Archives of …, 2016 - ncbi.nlm.nih.gov
Aim: An important life-threatening complication of intensive chemotherapy administered in
children with leukemia is febrile neutropenia. The objective of this study was to evaluate the …

[HTML][HTML] Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients

ES Horasan, G Ersoz, A Tombak, N Tiftik… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …